Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
37.21%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 41.46Close
$ 15.59 - $ 44.46 52-Week Range
Ticker Information
Ticker
CGONCompany Name
CG ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCG ONCOLOGY INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CGON - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 205K | 37.21% | $ 551K |
| 3/31/2025 | $ 19K | 2.87% | $ 662K |
| 12/31/2024 | $ 10K | 0.88% | $ 1.14M |
| 9/30/2024 | $ 17K | 2.49% | $ 684K |
| 12/31/2023 | $ 29K | 14.22% | $ 204K |
| 12/31/2022 | $ 32K | 16.75% | $ 191K |
Key Performance Insights, Last 5 Years
- CG ONCOLOGY INC's latest trailing twelve months (TTM) DepAmor % stands at 16.75%.
- Over the past 5 years, CG ONCOLOGY INC's average DepAmor % has been 12.4%.
- The median DepAmor % for CG ONCOLOGY INC during this period was 8.54%
- CG ONCOLOGY INC reached its highest DepAmor % over the past 5 years at 37.21%.
- The lowest DepAmor % recorded by CG ONCOLOGY INC in the same timeframe 0.88%
CG ONCOLOGY INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for CG ONCOLOGY INC is calculated as follows: DepAmor [ $ 32K ] / Revenues [ $ 191K ]
(=) DepAmor % [ 16.75% ] CGON - Depreciation and Amortization Margin, Last 5 years
0.88%
Minimum
Dec 31, 2024
37.21%
Maximum
Jun 30, 2025
12.4%
Average
8.54%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |